Overactive bladder Clinical Trials in Royal Oak, MI
As of June 2026, 1 paid clinical trial is recruiting for Overactive bladder in Royal Oak, Michigan. Recruiting Overactive bladder studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Royal Oak
Filter results
1 clinical trial for Overactive bladder
·Clear filters·↓ Download CSVAbout research studies in Royal Oak
Royal Oak has approximately 133 recruiting research studies across a wide range of therapeutic areas. Michigan hosts University of Michigan Health, Henry Ford Health, and Corewell Health, running trials across oncology, neurology, and cardiology with a strong focus on precision medicine.
Top Research Study Locations in Royal Oak
Researchers run research studies in Royal Oak, MI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Corewell Health William Beaumont University Hospital | Breast Cancer, Malignant Solid Neoplasm, Stage IIIB Lung Cancer AJCC v8 | 45 |
| William Beaumont Hospital | Aortic Stenosis, Aortic Stenosis, Severe, Aortic Valve Regurgitation | 19 |
| Corewell Health Children's | Acute Myeloid Leukemia, Ganglioneuroblastoma, Nodular, Metastatic Osteosarcoma | 18 |
| Cancer Care Associates PC | Breast Cancer, Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia | 9 |
| Comprehensive Medical Center PLLC | Breast Cancer, Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia | 9 |
| Hematology Oncology Consultants PC-Royal Oak | Breast Cancer, Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia | 9 |
| Oakland Colon Rectal Associates | Breast Cancer, Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia | 9 |
| Oakland Medical Group | Breast Cancer, Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia | 9 |
| Associated Retinal Consultants, P.C. | Age - Related Macular Degeneration (AMD), Geographic Atrophy (GA), Neovascular Age-related Macular Degeneration | 4 |
| Comprehensive Urology | Non-Muscle Invasive Bladder Neoplasms, High-Risk Non-Muscle-Invasive Bladder Cancer, Prostate Cancer Aggressiveness | 4 |
| Beaumont Hospital, Royal Oak | Blood Loss, Surgical, Coagulation Disorder, Idiopathic Pulmonary Fibrosis | 3 |
| Beaumont Health | Abdominal Aortic Aneurysm, Shoulder Arthritis, Shoulder Disease | 2 |
| Corewell Health | Acute Myocardial Infarction (AMI), Cardiovascular Risk, Moderate Aortic Valve Stenosis | 2 |
| Corewell Health William Beaum Hosp | Gastroenteropancreatic Neuroendocrine Carcinoma, Large Cell Neuroendocrine Carcinoma of the Lung, Neuroendocrine Prostate Cancer | 2 |
| Profound Research LLC | Advanced Breast Cancer, Breast Cancer, HER2- Negative Breast Cancer | 2 |
| Profound Research LLC at Michigan Hematology and Oncology Consultants | Advanced Breast Cancer, Breast Neoplasms | 2 |
| Associated Retinal Consultants | Neovascular Age-Related Macular Degeneration | 1 |
| Associated Retinal Consultants (ARC) P.C. | Choroidal Melanoma, Indeterminate Lesions, Ocular Melanoma | 1 |
| Associated Retinal Consultants - Royal Oak | Diabetic Macular Edema | 1 |
| Associated Retinal Consultants /ID# 256269 | AMD, CNV, Wet Age-related Macular Degeneration | 1 |
| Associated Retinal Consultants /ID# 263289 | Neovascular Age-related Macular Degeneration | 1 |
| Associated Retinal Consultants PC | Neovascular Age-related Macular Degeneration | 1 |
| Beaumont | Non-Small Cell Lung Cancer | 1 |
| Beaumont Breast Care Center | Breast Cancer | 1 |
| Beaumont Health System | Atrial Fibrillation | 1 |
Active & Upcoming Studies in Royal Oak (2026)
Recruiting trials in Royal Oak grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (60 active studies)
- A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer · Phase 1 · TerSera Therapeutics LLC
- Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors · Phase 1 · Novartis Pharmaceuticals
Cardiovascular (11 active studies)
- A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation · Boston Scientific Corporation
- Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) · Phase 3 · Reprieve Cardiovascular, Inc
Neurology & pain (7 active studies)
- Magnesium and Cramping · Phase 4 · Corewell Health East
- Sacral Neuromodulation for Chronic Pelvic Pain · Corewell Health East
Eye & vision (7 active studies)
- Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) · Phase 3 · AbbVie
- Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD · Phase 2 · ONL Therapeutics
Pediatric (1 active study)
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in Royal Oak
- Breast Cancer (6 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Malignant Solid Neoplasm (5 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Acute Myeloid Leukemia (3 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Advanced Breast Cancer (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Aortic Stenosis (3 active studies). Recruiting Aortic Stenosis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Atrial Fibrillation (3 active studies). Atrial fibrillation studies investigate next-generation anticoagulants, ablation technologies, and left atrial appendage closure devices.
Leading research sponsors in Royal Oak
- National Cancer Institute (NCI)
- Children's Oncology Group
- Corewell Health East
- NRG Oncology
- Alliance for Clinical Trials in Oncology
Local regulations and guidelines
Clinical trials in Michigan are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Michigan research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Royal Oak. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Royal Oak
Hipa.ai aggregates every recruiting study in Royal Oak from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Royal Oak?
There are approximately 133 recruiting clinical trials in Royal Oak, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Royal Oak pay participants?
Most recruiting trials in Royal Oak compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Royal Oak?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Royal Oak?
The most common conditions under active study in Royal Oak include Breast Cancer (6), Malignant Solid Neoplasm (5), Acute Myeloid Leukemia (3), Advanced Breast Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Royal Oak?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Royal Oak on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Royal Oak?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Royal Oak?
Recruiting research sites in Royal Oak include Corewell Health William Beaumont University Hospital, William Beaumont Hospital, Corewell Health Children's, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Royal Oak right now?
The largest active categories in Royal Oak are Cancer & tumors (60), Cardiovascular (11), Neurology & pain (7). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.